Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jonathan C. Prather"'
Autor:
Miha Arnol, Douglas J. Norman, Jonathan C. Prather, Angelo M. de Mattos, Anuja Mittalhenkle, Jae S. Chung
Publikováno v:
Transplantation. 86:1844-1848
Cardiovascular events (CVE) are the leading cause of mortality in kidney transplant recipients. The adverse effects of long-term therapy with steroids on cardiovascular risk have motivated increasing interest in steroid withdrawal (SW). The objective
Long-Term Kidney Regraft Survival From Deceased Donors: Risk Factors and Outcomes in a Single Center
Publikováno v:
Transplantation. 86:1084-1089
Background Although survival of kidney regrafts is similar to that of primary grafts, risk factors associated with regraft survival have not been defined clearly. The aim of this study was to investigate risk factors for regraft outcome, including ch
Autor:
Jean Tchervenkov, Douglas J. Norman, Steven Paraskevas, Angelo M DeMattos, Douglas S. Keith, Marcelo Cantarovich, Jonathan C. Prather, Muralikrishna Golconda
Publikováno v:
Journal of the American Society of Nephrology. 16:1512-1521
The decade of the 1990s saw an improvement in cadaveric renal graft function and dramatic reduction in the acute rejection (AR) rate. The purpose of this study was to determine whether the reduction in rejection rate was the primary cause of the impr
Autor:
Jonathan C. Prather, Angelo M. de Mattos, Muralikrishna Golconda, Ali J. Olyaei, John M. Barry, Douglas J. Norman
Publikováno v:
Kidney International. 67(2):714-720
Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.BackgroundPosttransplant diabetes mellitus is an important complication of renal transplantation that is associated with a significant
Autor:
Douglas S. Keith, Douglas J. Norman, Angelo M DeMattos, Jonathan C. Prather, Muralikrishna Golconda
Publikováno v:
Journal of the American Society of Nephrology. 15:1086-1091
Donor-recipient age matching has been proposed as a means of improving overall outcomes in deceased donor renal transplantation. It was hypothesized that donor-recipient age matching would improve patient survival time in younger recipients while not
Autor:
Douglas J. Norman, Jonathan C. Prather, Michael J. Conlin, John M. Barry, G. Mogilishetty, Angelo M. de Mattos, Gregory S. Taylor
Publikováno v:
Journal of Urology. 174:223-225
Purpose: Living, genetically unrelated donor renal transplantation (LURT) is being performed with increasing frequency. We evaluated our single center experience with LURT and compared this to a cohort of living related donor renal transplants (LRT)
Publikováno v:
The Journal of urology. 177(6)
An algorithm was developed for performing bilateral nephrectomies for specific indications before or at renal transplantation in patients with autosomal dominant polycystic kidney disease. Outcomes for the living donor arm of the algorithm are report
Autor:
M. Mori, A M de Mattos, Yugo Shibagaki, Douglas J. Norman, Thomas M. Becker, Douglas S. Keith, Jonathan C. Prather, Ali J. Olyaei
Publikováno v:
Kidney international. 70(4)
Cardiovascular mortality is increased in transplant recipients. However, studies including non-fatal events are critical to assess the burden of disease and to identify novel risk factors. We described the incidence of fatal and non-fatal events, and
Autor:
Linda K, Goodwin, Jonathan C, Prather
Publikováno v:
Journal of healthcare information management : JHIM. 16(4)
This paper investigates whether HIPAA de-identification requirements--as well as proposed AAMC de-identification standards--were met in a large clinical data mining study (1997-2001) conducted at Duke University prior to the publication of the final
Autor:
Ahmed M. Alkhunaizi, Douglas J. Norman, John M. Barry, Angelo M DeMattos, Muralikrishna Golconda, Jonathan C. Prather
Publikováno v:
Transplantation proceedings. 33(7-8)
DURING the past several years there has been an increased concern about the discrepancy in waiting times among patients with different ABO blood groups. Specifically, data from the U.S. Scientific Registry indicate that patients with blood group B wa